Cargando…
Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India”
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653521/ https://www.ncbi.nlm.nih.gov/pubmed/34896157 http://dx.doi.org/10.1016/j.radonc.2021.12.001 |
| _version_ | 1784611683040231424 |
|---|---|
| author | Ganesan, Govindaraj Ponniah, Sasipriya Sundaram, Vivek Marimuthu, Praveen Kumar Pitchaikannu, Venkatraman Chandrasekaran, Manigandan Thangarasu, Janakiraman Kannupaiyan, Gunasekaran Ramamoorthy, Prabhu Thangaraj, Brindha Vaishnavi, Raguram Shree |
| author_facet | Ganesan, Govindaraj Ponniah, Sasipriya Sundaram, Vivek Marimuthu, Praveen Kumar Pitchaikannu, Venkatraman Chandrasekaran, Manigandan Thangarasu, Janakiraman Kannupaiyan, Gunasekaran Ramamoorthy, Prabhu Thangaraj, Brindha Vaishnavi, Raguram Shree |
| author_sort | Ganesan, Govindaraj |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8653521 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86535212021-12-08 Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” Ganesan, Govindaraj Ponniah, Sasipriya Sundaram, Vivek Marimuthu, Praveen Kumar Pitchaikannu, Venkatraman Chandrasekaran, Manigandan Thangarasu, Janakiraman Kannupaiyan, Gunasekaran Ramamoorthy, Prabhu Thangaraj, Brindha Vaishnavi, Raguram Shree Radiother Oncol Letter to the Editor Published by Elsevier B.V. 2022-02 2021-12-08 /pmc/articles/PMC8653521/ /pubmed/34896157 http://dx.doi.org/10.1016/j.radonc.2021.12.001 Text en © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ganesan, Govindaraj Ponniah, Sasipriya Sundaram, Vivek Marimuthu, Praveen Kumar Pitchaikannu, Venkatraman Chandrasekaran, Manigandan Thangarasu, Janakiraman Kannupaiyan, Gunasekaran Ramamoorthy, Prabhu Thangaraj, Brindha Vaishnavi, Raguram Shree Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title | Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_full | Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_fullStr | Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_full_unstemmed | Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_short | Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_sort | response to comments on “whole lung irradiation as a novel treatment for covid-19: interim results of an ongoing phase 2 trial in india” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653521/ https://www.ncbi.nlm.nih.gov/pubmed/34896157 http://dx.doi.org/10.1016/j.radonc.2021.12.001 |
| work_keys_str_mv | AT ganesangovindaraj responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT ponniahsasipriya responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT sundaramvivek responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT marimuthupraveenkumar responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT pitchaikannuvenkatraman responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT chandrasekaranmanigandan responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT thangarasujanakiraman responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT kannupaiyangunasekaran responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT ramamoorthyprabhu responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT thangarajbrindha responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT vaishnaviraguramshree responsetocommentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia |